TrialJournal of diabetes2024

Impact of chiglitazar on glycemic control in type 2 diabetic patients with metabolic syndrome and insulin resistance: A pooled data analysis from two phase III trials.

Zhiqiang Ning et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.